Antiplatelet therapy

Case Report

Stenting Temporarily Unprotected by Platelet Inhibitor Drugs (an unplanned case study)

04/03/2015

A 64-year-old gentleman presented to the emergency department with 6 hours of intermittent substernal chest pressure associated with mild diaphoresis and dyspnea.

A 64-year-old gentleman...

04/03/2015

Cath Lab Digest

Economics and Care

Switching From Eptifibatide to Tirofiban Use in ACS: Reducing Cost While Maintaining Quality of Care

02/26/2015

Joseph Brent Muhlestein , MD, FAHA, FACC;

An emphasis on consensus and partnership allows Intermountain Health Care to unite under treatment guidelines, establish protocols, and save money, all while providing quality patient care.

An emphasis on consensus and...

02/26/2015

Cath Lab Digest

Original Contribution

In-Hospital Management and Outcome of Patients on Warfarin Undergoing Coronary Stent Implantation: Results of the Multicenter, Prospective WARfarin and Coronary STENTing (WAR-STENT) Registry

04/01/2013

Giacomo Piccalo , MD;

Elisabetta Varani , MD;

Massimo Margheri , MD;

Leonardo Bolognese , MD;

Giuseppe Di Pasquale , MD;

Alessandro Sciahbasi , MD, PhD;

Marcello Galvani , MD;

Lucio Gonzini , BSc;

Andrea Rubboli , MD;

Aldo Pietro Maggioni , MD;

Francesco Saia , MD, PhD;

Cataldo Palmieri , MD;

Luigi Andrea Moroni , MD;

Paolo Calabro , MD;

Antonio Maria Leone , MD, PhD;

Nicoletta Franco , MD;

Carlo Briguori , MD, PhD;

Marco Valgimigli , MD, PhD, FESC;

Michela Santi , MD;

Paola Pasqualini , MD;

Alessandro Capecchi , MD;

To determine the adherence to the current recommendations, and the incidence of adverse events, we carried out the prospective, multi-center, observational WARfarin and coronary STENTing (WAR-STENT) registry. All consecutive patients on...

To determine the adherence to...

04/01/2013

Journal of Invasive Cardiology